Comerica Bank cut its stake in Integer Holdings Co. (NYSE:ITGR – Get Rating) by 9.0% in the third quarter, HoldingsChannel.com reports. The fund owned 28,128 shares of the medical equipment provider’s stock after selling 2,787 shares during the period. Comerica Bank’s holdings in Integer were worth $1,583,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently modified their holdings of the company. Covestor Ltd grew its stake in shares of Integer by 420.6% during the 1st quarter. Covestor Ltd now owns 328 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 265 shares during the period. First Horizon Advisors Inc. increased its holdings in Integer by 6,370.0% during the second quarter. First Horizon Advisors Inc. now owns 647 shares of the medical equipment provider’s stock valued at $46,000 after buying an additional 637 shares during the last quarter. Captrust Financial Advisors raised its position in Integer by 56.3% in the first quarter. Captrust Financial Advisors now owns 2,408 shares of the medical equipment provider’s stock worth $194,000 after acquiring an additional 867 shares during the period. Summit Trail Advisors LLC purchased a new position in shares of Integer during the 2nd quarter worth $200,000. Finally, Versor Investments LP purchased a new stake in shares of Integer in the 2nd quarter worth $217,000. Institutional investors own 98.42% of the company’s stock.
Integer Stock Up 1.3 %
Shares of ITGR opened at $74.21 on Friday. Integer Holdings Co. has a 12-month low of $50.05 and a 12-month high of $88.58. The company has a current ratio of 2.80, a quick ratio of 1.74 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $2.46 billion, a PE ratio of 34.52 and a beta of 1.17. The business’s 50 day moving average is $70.58 and its 200 day moving average is $66.75.
Insider Transactions at Integer
In other Integer news, CEO Joseph W. Dziedzic purchased 4,000 shares of the stock in a transaction that occurred on Friday, December 16th. The stock was purchased at an average price of $61.95 per share, with a total value of $247,800.00. Following the acquisition, the chief executive officer now owns 122,378 shares in the company, valued at $7,581,317.10. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.01% of the company’s stock.
Analyst Ratings Changes
Several analysts have issued reports on the company. StockNews.com initiated coverage on Integer in a report on Wednesday, October 12th. They set a “hold” rating for the company. Benchmark decreased their target price on shares of Integer to $90.00 in a research note on Tuesday, November 1st. Finally, KeyCorp dropped their price target on shares of Integer from $97.00 to $84.00 and set an “overweight” rating for the company in a research report on Thursday, October 6th.
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.
- Get a free copy of the StockNews.com research report on Integer (ITGR)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.